1988
DOI: 10.2131/jts.13.supplementii_63
|View full text |Cite
|
Sign up to set email alerts
|

REPRODUCTION STUDIES OF CARBOPLATIN(III) : Intravenous administration to rats during the perinatal and lactation periods

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

1989
1989
2012
2012

Publication Types

Select...
3
2

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(1 citation statement)
references
References 5 publications
0
1
0
Order By: Relevance
“…In these rodents no teratogenic effects were detected when carboplatin was administered from day 7 to 17 of gestation. However, treatment in early pregnancy during organogenisis induced intra-uterine death and congenital malformations like gastroschisis, dilatation of cerebral ventricles, or skeletal malformations [42][43][44][45]. Therefore, cytotoxic treatment should be reserved to the later stages of pregnancy and abortion has to be considered in patients scheduled for chemotherapy during organogensis.…”
Section: Chemotherapy During Pregnancymentioning
confidence: 99%
“…In these rodents no teratogenic effects were detected when carboplatin was administered from day 7 to 17 of gestation. However, treatment in early pregnancy during organogenisis induced intra-uterine death and congenital malformations like gastroschisis, dilatation of cerebral ventricles, or skeletal malformations [42][43][44][45]. Therefore, cytotoxic treatment should be reserved to the later stages of pregnancy and abortion has to be considered in patients scheduled for chemotherapy during organogensis.…”
Section: Chemotherapy During Pregnancymentioning
confidence: 99%